Abstract:The poor prognosis of patients with osteosarcoma remains a persistent problem, in particular for patients with unresectable tumors or metastasis. Therefore, combination of radiotherapy and chemotherapy has been considered for patients with metastasis or recurrence, patients unsuitable for surgery and patients refusing surgery. The present study aimed to investigate the effect of the combined treatment with cisplatin and radiation therapy on the biological characteristics of the osteosarcoma cell line MG-63 and the breast cancer 1 (BRCA1)-associated signaling pathways. Cell proliferation was determined using Cell Counting kit-8 assay, and cell apoptosis and cell cycle were assessed by flow cytometry. Cell migration was examined by Transwell assay. The mRNA and protein expression levels of candidate genes, including BRCA1 and p53, were determined by reverse transcription-quantitative PCR and western blotting, respectively. The results demonstrated that combined treatment with radiation and cisplatin significantly inhibited MG-63 cell proliferation compared with radiation or cisplatin treatment alone. Furthermore, radiation, cisplatin or the combined treatment with radiation and cisplatin increased the apoptosis rate of MG-63 cells, which resulted in G2 phase arrest, and significantly decreased the migratory capacity of MG-63 cells. In addition, the apoptosis rate of MG-63 cells following combined radiation and cisplatin treatment was higher compared with the cisplatin group, but lower compared with the radiation group. Furthermore, combined treatment with radiation and cisplatin decreased the mRNA and protein expression levels of BRCA1 and p53. Additionally, combined treatment with radiation and cisplatin had a more potent inhibitory effect on p53 expression than on BRCA1 expression. In addition, combination of radiation and cisplatin had a higher inhibitory effect on Bax protein level and a higher inductive effect on Bcl-2 protein level compared with treatments with radiation and cisplatin alone. The results demonstrated that combined treatment of radiation and cisplatin exhibited superior therapeutic effects on osteosarcoma MG-63 cells compared with radiation or cisplatin treatment alone, which may be mediated by the BRCA1-p53 signaling pathway.

Efficacy of celastrol combined with cisplatin in enhancing the apoptosis of U-2OS osteosarcoma cells via the mitochondrial and endoplasmic reticulum pathways of apoptosis.

Synergistic Apoptotic Effect of Crocin and Cisplatin on Osteosarcoma Cells Via Caspase Induced Apoptosis.

Efficient Killing Effect of Osteosarcoma Cells by Cinobufacini and Cisplatin in Combination.

Enhancement of Osteosarcoma Cell Sensitivity to Cisplatin Using Paclitaxel in the Presence of Hyperthermia

Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway

Celastrol Induces Apoptosis and Autophagy Via the ROS/JNK Signaling Pathway in Human Osteosarcoma Cells: an in Vitro and in Vivo Study

Effect and Mechanisms of Celastrol on the Apoptosis of HOS Osteosarcoma Cells.

Effect of Cinobufacini plus Cisplatin on the Proliferation and Apoptosis of Osteosarcoma U2OS Cells

Celastrol promotes apoptosis of human osteosarcoma HOS cells through endoplasmic reticulum stress pathway

Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the C-Myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses.

Celastrol Negatively Regulates Cell Invasion and Migration Ability of Human Osteosarcoma Via Downregulation of the PI3K/Akt/NF-κB Signaling Pathway in Vitro.

The Synergistic Effects of Celastrol in Combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells

Experimental Study on Caffeine and Cisplatin Induction Apoptosis of Osteosarcoma Cell Line(os-732)

Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway

Celecoxib Enhances Anticancer Effect of Cisplatin and Induces Anoikis in Osteosarcoma Via PI3K/Akt Pathway.

In vitro cytotoxicity of cisplatin combined with carboplatin on osteosarcoma cell line OS-732

ABT-737 Potentiates Cisplatin-Induced Apoptosis in Human Osteosarcoma Cells Via the Mitochondrial Apoptotic Pathway.

The Inhibitory Effects of Cisplatin-Radiation Combination Treatment on Malignant Osteosarcoma MG-63 Cells and BRCA1-p53 Pathways Are More Efficient Than Single Treatments.

Synergistic Growth Inhibition by Sorafenib and Cisplatin in Human Osteosarcoma Cells

Blockade of survivin promotes the apoptosis of human osteosarcoma cell line U-2OS

[Cytotoxic Effect of Cisplatin with Proteasome Inhibitor on Osteosarcoma Cells].